My NCBI | Sign In
RSS Settings
  • Search: "Tsutani K"[Author]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 35

    1.

    Effectiveness of Aquatic Exercise and Balneotherapy: A Summary of Systematic Reviews Based on Randomized Controlled Trials of Water Immersion Therapies.

    Kamioka H, Tsutani K, Okuizumi H, Mutoh Y, Ohta M, Handa S, Okada S, Kitayuguchi J, Kamada M, Shiozawa N, Honda T.

    J Epidemiol. 2009 Oct 31. [Epub ahead of print]PMID: 19881230 [PubMed - as supplied by publisher]Related articlesFree article

    2.

    Cost-effectiveness analysis of capecitabine compared with bolus 5-fluorouracil/l-leucovorin for the adjuvant treatment of colon cancer in Japan.

    Shiroiwa T, Fukuda T, Shimozuma K, Ohashi Y, Tsutani K.

    Pharmacoeconomics. 2009;27(7):597-608. doi: 10.2165/11310110-000000000-00000.PMID: 19663530 [PubMed - indexed for MEDLINE]Related articles

    3.

    Health utility scores of colorectal cancer based on societal preference in Japan.

    Shiroiwa T, Fukuda T, Tsutani K.

    Qual Life Res. 2009 Oct;18(8):1095-103. Epub 2009 Jul 21.PMID: 19626462 [PubMed - in process]Related articles

    4.

    Cost-effectiveness analysis of XELOX for metastatic colorectal cancer based on the NO16966 and NO16967 trials.

    Shiroiwa T, Fukuda T, Tsutani K.

    Br J Cancer. 2009 Jul 7;101(1):12-8. Epub 2009 Jun 2.PMID: 19491895 [PubMed - indexed for MEDLINE]Related articles

    5.

    Current status of Kampo (Japanese herbal) medicines in Japanese clinical practice guidelines.

    Motoo Y, Arai I, Hyodo I, Tsutani K.

    Complement Ther Med. 2009 Jun;17(3):147-54. Epub 2008 Nov 14. Review.PMID: 19398068 [PubMed - indexed for MEDLINE]Related articles

    6.

    International survey on willingness-to-pay (WTP) for one additional QALY gained: what is the threshold of cost effectiveness?

    Shiroiwa T, Sung YK, Fukuda T, Lang HC, Bae SC, Tsutani K.

    Health Econ. 2009 Apr 20. [Epub ahead of print]PMID: 19382128 [PubMed - as supplied by publisher]Related articles

    7.

    Cost-utility analysis of varenicline, an oral smoking-cessation drug, in Japan.

    Igarashi A, Takuma H, Fukuda T, Tsutani K.

    Pharmacoeconomics. 2009;27(3):247-61. doi: 10.2165/00019053-200927030-00007.PMID: 19354344 [PubMed - indexed for MEDLINE]Related articles

    8.

    [From ethnic difference to ethnic similarity. Foreword]

    Tsutani K, Nakajima K.

    Yakugaku Zasshi. 2009 Feb;129(2):209-11. Japanese. No abstract available. PMID: 19182449 [PubMed - indexed for MEDLINE]Related articlesFree article

    9.

    Personal imports of drugs to Japan in 2005--an analysis of import certificates.

    Tsuji K, Tsutani K.

    J Clin Pharm Ther. 2008 Oct;33(5):545-52.PMID: 18834370 [PubMed - indexed for MEDLINE]Related articles

    10.

    Follow the leader.

    Tsuji K, Tsutani K.

    Nature. 2008 Jun 12;453(7197):851-2. No abstract available. PMID: 18548049 [PubMed - indexed for MEDLINE]Related articles

    11.

    Regulatory sciences in herbal medicines and dietary supplements.

    Tsutani K, Takuma H.

    Yakugaku Zasshi. 2008 Jun;128(6):867-80. Review.PMID: 18520134 [PubMed - indexed for MEDLINE]Related articlesFree article

    12.

    Safety securing and safety monitoring of herbal medicines, finished herbal products and supplements.

    Toriizuka K, Tsutani K.

    Yakugaku Zasshi. 2008 Jun;128(6):835-6. No abstract available. PMID: 18520129 [PubMed - indexed for MEDLINE]Related articlesFree article

    13.

    Cost-effectiveness analysis of bevacizumab combined with chemotherapy for the treatment of metastatic colorectal cancer in Japan.

    Shiroiwa T, Fukuda T, Tsutani K.

    Clin Ther. 2007 Oct;29(10):2256-67.PMID: 18042483 [PubMed - indexed for MEDLINE]Related articles

    14.

    Approval of new biopharmaceuticals 1999-2006: comparison of the US, EU and Japan situations.

    Tsuji K, Tsutani K.

    Eur J Pharm Biopharm. 2008 Mar;68(3):496-502. Epub 2007 Aug 10.PMID: 17884403 [PubMed - indexed for MEDLINE]Related articles

    15.

    [A systematic review of randomized controlled trials of exercise and lifestyle intervention for the health promotion of older adults--issues and an effective model of intervention]

    Takahashi M, Kamioka H, Tsutani K, Muto Y.

    Nippon Ronen Igakkai Zasshi. 2007 Jul;44(4):403-14. Review. Japanese. No abstract available. PMID: 17853532 [PubMed - indexed for MEDLINE]Related articles

    16.

    The model-based cost-effectiveness analysis of 1-year adjuvant trastuzumab treatment: based on 2-year follow-up HERA trial data.

    Shiroiwa T, Fukuda T, Shimozuma K, Ohashi Y, Tsutani K.

    Breast Cancer Res Treat. 2008 Jun;109(3):559-66. Epub 2007 Jul 28.PMID: 17661170 [PubMed - indexed for MEDLINE]Related articles

    17.

    Awareness survey of parties involved in pharmacogenomics in Japan.

    Tamaoki M, Gushima H, Tsutani K.

    Pharmacogenomics. 2007 Mar;8(3):275-86.PMID: 17324116 [PubMed - indexed for MEDLINE]Related articles

    18.

    A health economic evaluation of aspirin in the primary prevention of cardiovascular disease in Japan.

    Tsutani K, Igarashi A, Fujikawa K, Evers T, Kubin M, Lamotte M, Annemans L.

    Intern Med. 2007;46(4):157-62. Epub 2007 Feb 15.PMID: 17301509 [PubMed - indexed for MEDLINE]Related articlesFree article

    19.

    1st DIA Annual Japan Workshop for Pharmacogenomics in Tokyo.

    Tamaoki M, Gushima H, Tsutani K.

    Pharmacogenomics. 2005 Mar;6(2):103-9. No abstract available. PMID: 15882129 [PubMed - indexed for MEDLINE]Related articles

    20.

    [Anti-rheumatoid biologics and pharmacoeconomic evaluation]

    Tsutani K, Igarashi A.

    Nippon Rinsho. 2005 Jan;63 Suppl 1:711-8. Review. Japanese. No abstract available. PMID: 15799447 [PubMed - indexed for MEDLINE]Related articles

    Supplemental Content

    Filter your results:

    Find related data

    Search details

    » See more...

    Recent activity